Table 2.
Characteristics and design considerations of several delivery systems
| Delivery systems | Formation | Functional characteristics | Design considerations | References |
|---|---|---|---|---|
| Polymer-based nanoparticles | Composed of natural/synthetic high polymer | The loaded active compounds can be embedded in the polymer core or adsorbed onto the polymer core surface | Controlled delivery of vaccines is achieved by controlling size, shape, and surface characteristics | [115, 116] |
| Liposome-based nanoparticles | The composition includes lipids that can be ionized, cholesterol, phospholipids, and lipids modified with polyethylene glycol | Can encapsulate water-soluble and fat-soluble drugs, has a high degree of targeting, can effectively protect the encapsulated drugs, and can control and slowly release drugs | Its formulation composition, size, and surface charge affect its efficacy and pharmacokinetics, and these factors can be controlled to optimize vaccine delivery | [117, 118] |
| Hydrogels | High hydrophilic polymers form three-dimensional network structures by cross-linking in water | High doses of non-specific drug distribution can be accurately delivered to specific sites while achieving continuous controlled release of drug molecules | Generally, drug-containing hydrogels are mainly diffused and released by controlling the degradation, swelling, and mechanical deformation of the hydrogel mesh, ultimately leading to controlled drug release | [119–121] |
| Microneedles | Consists of a plurality of micrometer small needle tips connected in an array on the base | Can be directed through the stratum corneum, avoiding blood vessels and nerves to deliver the drug precisely and effectively below the stratum corneum; allows the active ingredient to be released in a continuous or controlled manner | The length, size, and shape of the microneedles determine their mechanical properties, insertion capacity, drug-loading capacity, and drug-delivery efficiency and can be individually designed according to therapeutic needs | [122, 123] |